Generation of high concentrations of respirable solid-phase aerosols from viscous fluids

References

• Anzueto, A., Baughman, R. P., Guntupalli, K. K., Weg, J. G., Wiedemann, H. P., Raventos, A. A., Lemaire, F., Long, W., Zaccardelli, D. S., and Pattishall, E. N. (1996). Aerosolized Surfactant in Adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N. Engl. J. Med., 334:1417–1422.
   PubMed Web of Science ®Google Scholar
• Brand, P., Schulte, M., Wencker, M., Herpich, C. H., Klein, G., Hanna, K., and Meyer, T. (2009). Lung Deposition of Inhaled Alpha1-Proteinase Inhibitor in Cystic Fibrosis and Alpha1-Antitrypsin Deficiency . Eur. Respir. J., 34:354–360.
   PubMed Web of Science ®Google Scholar
• Chan, J. G., Traini, D., Chan, H. K., Young, P. M., and Kwok, P. C. (2012). Delivery of High Solubility Polyols by Vibrating Mesh Nebulizer to Enhance Mucociliary Clearance. J. Aerosol Med. Pulm. Drug. Deliv., 25:297–305.
   PubMed Web of Science ®Google Scholar
• Chan, J. G. Y., Tyne, A. S., Pang, A., Chan H. K., Young, P. M., Britton, W. J., Duke, C. C., and Traini, D. (2014). A Rifapentine-Containing Inhaled Triple Antibiotic Formulation for Rapid Treatment of Tubercular Infection. Pharm. Res., 31:1239.
   PubMed Web of Science ®Google Scholar
• Clancy, J. P., Dupont, L., Konstan, M. W., Billings, J., Fustik, S., Goss, C. H., Lymp, J., Minic, P., Quittner, A. L., Rubenstein, R. C., Young, K. R., Saiman, L., Burns, J. L., Govan, J. R. W., Ramsey, B., and Gupta, R. (2013). Phase II Studies of Nebulised Arikace in CF Patients with Pseudomonas aeruginosa Infection. Thorax, 68:818–825.
   PubMed Web of Science ®Google Scholar
• Das, S., Tucker, I., and Stewart, P. (2015). Inhaled Dry Powder Formulations for Treating Tuberculosis. Curr Drug Deliv, 12:26–39.
   PubMed Web of Science ®Google Scholar
• Davies, L. A., Nunez-Alonso, G. A., McLachlan, G., Hyde, S. C., and Gill, D. R. (2014). Aerosol Delivery of DNA/Liposomes to the Lung for Cystic Fibrosis Gene Therapy. Hum. Gene Ther. Clin. Dev., 25:97–107.
   PubMed Web of Science ®Google Scholar
• Dushianthan, A., Goss, V., Cusack, R., Grocott, M. P., and Postle, A. D. (2014). Altered Molecular Specificity of Surfactant Phosphatidycholine Synthesis in Patients with Acute Respiratory Distress Syndrome. Respir. Res., 15:128.
   PubMed Web of Science ®Google Scholar
• Eistetter, K. (2001). Process for the production of powdered pulmonary surfactant preparations. Patent No US 6215983.
   Google Scholar
• Finlay, W. H. (2001). The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction. London: Academic Press.
   Google Scholar
• Frederiksen, B., Pressler, T., Hansen, A., Koch, C., and Høiby, N. (2006). Effect of Aerosolized rhDNase (Pulmozyme) on Pulmonary Colonization in Patients with Cystic Fibrosis. Acta Paediatr., 95:1070–1074.
   PubMed Web of Science ®Google Scholar
• Gañán-Calvo, A. M. (2005). Enhanced Liquid Atomization: From Flow-Focusing to Flow-Blurring. Appl. Phys. Lett., 86:214101.
   Web of Science ®Google Scholar
• Gañán-Calvo, A. M., and Montanero, J. M. (2009). Revision of Capillary Cone-Jet Physics: electrospray and Flow Focusing. Phys. Rev. E Stat. Nonlin. Soft Matter Phys., 79:066305
   PubMed Web of Science ®Google Scholar
• Ghazanfari, T., Elhissi, A. M., Ding, Z., and Taylor, K. M. (2007). The Influence of Fluid Physicochemical Properties on vibrating-mesh nebulization. Int. J. Pharm., 339:103–111.
   PubMed Web of Science ®Google Scholar
• Gordon, M. S., Thomas, T., and Weers, J. (2003). Inhalation lung surfactant therapy. Patent application 60333729.
   Google Scholar
• Griese, M., and Scheuch, G. (2016). Delivery of Alpha-1 Antitrypsin to Airways. Annals Ats., 13:S346–S351.
   Web of Science ®Google Scholar
• Gugliotti, M., Baptista, M. S., and Politi, M. J. (2005). Reduction of Evaporation of Natural Water Samples by Monomolecular Films. J. Braz. Chem. Soc., 16:1186–1190.
   Web of Science ®Google Scholar
• Guilleminault, L., Azzopardi, N., Arnoult, C., Sobilo, J., Hervé, V., Montharu, J., Guillon, A., Andres, C., Herault, O., Le Pape, A., Diot, P., Lemarié, E., Paintaud, G., Gouilleux-Gruart, V., and Heuzé-Vourc'h, N. (2014). Fate of Inhaled Monoclonal Antibodies after the Deposition of Aerosolized Particles in the Respiratory System. J Control Release, 196:344–354.
   PubMed Web of Science ®Google Scholar
• Gurjar, M. (2015). Colistin for Lung Infection: An Update. J Intensive Care, 3:3.
   PubMed Web of Science ®Google Scholar
• Hsiang, L. P., and Faeth, G. M. (1992). Near-Limit Drop Deformation and Secondary Breakup. Int. J. Multiph. Flow, 18:635–652.
   Web of Science ®Google Scholar
• Hütten, M. C., Kuypers, E., Ophelders, D. R., Nikiforou, M., Jellema, R. K., Niemarkt, H. J., Fuchs, C., Tservistas, M., Razetti, R., Bianco, F., and Kramer, B. W. (2015). Nebulization of Poractant Alfa via a Vibrating Membrane Nebulizer in Spontaneously Breathing Preterm Lambs with Binasal Continuous Positive Pressure Ventilation. Pediatr. Res., 78:664–669.
   PubMed Web of Science ®Google Scholar
• Joshi, N., Shirsath, N., Singh, A., Joshi, K. S., and Banerjee, R. (2014). Endogenous Lung Surfactant Inspired pH Responsive Nanovesicle Aerosols: Pulmonary Compatible and Site-Specific Drug Delivery in Lung metastases. Sci. Rep., 4:7085.
   PubMed Web of Science ®Google Scholar
• Kryeziu, O., and Johnson, E. R. (2013). Subsonic to Supersonic Nozzle Flows. SIAM J. Appl. Math, 73:175–194.
   Web of Science ®Google Scholar
• Lehofer, B., Bloder, F., Jain, P. P., Marsh, L. M., Leitinger, G., Olschewski, H., Leber, R., Olschewski, A., and Prassl, R. (2014). Impact of Atomization Technique on the Stability and Transport Efficiency of Nebulized Liposomes Harboring Different Surface Characteristics. Eur. J. Pharm. Biopharm., 88:1076–1085.
   PubMed Web of Science ®Google Scholar
• Lentz, Y. K., Anchordoquy, T. J., and Lengsfeld, C. S. (2006). Rationale for the Selection of an Aerosol Delivery System for Gene delivery. J. Aerosol Med., 19:372–384.
   PubMedGoogle Scholar
• Lewis, J. F., Ikegami, M., Jobe, A. H., and Tabor, B. (1991). Aerosolized Surfactant Treatment of Preterm Lambs. J. Appl. Physiol., 70:869–876.
   PubMed Web of Science ®Google Scholar
• Liu, C., Zhang, Y. T., Peng, Z. Y., Zhou, Q., Hu, B., Zhou, H., and Li, J. G. (2017). Aerosolized Amikacin as Adjunctive Therapy of Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria: A Single-Center Randomized Controlled Trial. Chin. Med. J., 130:1196.
   PubMed Web of Science ®Google Scholar
• Maa, Y. F., Nguyen, P. A., Andya, J. D., Dasovich, N., Sweeney, T. D., Shire, S. J., and Hsu, C. C. (1998). Effect of Spray Drying and Subsequent Processing Conditions on Residual Moisture Content and Physical/Biochemical Stability of Protein Inhalation Powders. Pharm. Res., 15:768–775.
   PubMed Web of Science ®Google Scholar
• Maillet, A., Guilleminault, L., Lemarié, E., Lerondel, S., Azzopardi, N., Montharu, J., Congy-Jolivet, N., Reverdiau, P., Legrain, B., Parent, C., Douvin, D.-H., Hureaux, J., Courty, Y., De Monte, M., Diot, P., Paintaud, G., Le Pape, A., Watier, H., and Heuzé-Vourc'h, N. (2011). The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors. Pharm. Res., 28:2147–2156.
   PubMed Web of Science ®Google Scholar
• Majithia, A. K., Hall, S., Harper, L., and Bowen, P. J. (2008). Droplet breakup quantification and processes in constant and pulsed air flows. In Proceedings of the 22nd Conference on Liquid Atomization and Spray Systems (ILASS-Europe), Como Lake, Italy, September 8–10.
   Google Scholar
• Maselli, D. J., Keyt, H., and Restrepo, M. I. (2017). Inhaled Antibiotic Therapy in Chronic Respiratory Diseases. IJMS., 18:1062.
   Web of Science ®Google Scholar
• McCallion, O. N., Taylor, K. M., Thomas, M., and Taylor, A. J. (1995). Nebulization of Fluids of Different Physicochemical Properties with Air-Jet and Ultrasonic Nebulizers. Pharm. Res., 12:1682–1688.
   PubMed Web of Science ®Google Scholar
• Pohlmann, G., Iwatschenko, P., Koch, W., Windt, H., Rast, M., de Abreu, M. G., Taut, F. J., and De Muynck, C. (2013). A Novel Continuous Powder Aerosolizer (CPA) for Inhalative Administration of Highly Concentrated Recombinant Surfactant Protein-C (rSP-C) Surfactant to Preterm Neonates. J. Aerosol Med. Pulm. Drug Deliv., 26:370–379.
   PubMed Web of Science ®Google Scholar
• Rahmel, D. K., Pohlmann, G., Iwatschenko, P., Volland, J., Liebisch, S., Kock, H., Mecklenburg, L., Maurer, C., Kemkowski, J., and Taut, F. J. (2012). The Non-Intubated, Spontaneously Breathing, Continuous Positive Airway Pressure (CPAP) Ventilated Pre-Term Lamb: A Unique Animal Model. Reprod. Toxicol., 34:204–215.
   PubMed Web of Science ®Google Scholar
• Rajagopal, K., Wood, J., Tran, B., Patapoff, T. W., and Nivaggioli, T. (2013). Trehalose Limits BSA Aggregation in Spray-Dried Formulations at High Temperatures: Implications in Preparing Polymer Implants for Long-Term Protein Delivery. J. Pharm. Sci., 102:2655–2666.
   PubMed Web of Science ®Google Scholar
• Ramezani, V., Vatanara, A., Najafabadi, A. R., Shokrgozar, M. A., Khabiri, A., and Seyedabadi, M. (2014). A Comparative Study on the Physicochemical and Biological Stability of IgG 1 and Monoclonal Antibodies during Spray Drying Process. Daru J., 22:31.
   PubMed Web of Science ®Google Scholar
• Ricci, F., Salomone, F., Kuypers, E., Ophelders, D., Nikiforou, M., Willems, M., Krieger, T., Murgia, X., Hutten, M., Kramer, B. W., and Bianco, F. (2017). In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome. Front. Pediatr., 5:186.
   PubMed Web of Science ®Google Scholar
• Rijnders, B. J., Cornelissen, J. J., Slobbe, L., Becker, M. J., Doorduijn, J. K., Hop, W. C. J., Ruijgrok, E. J., Löwenberg, B., Vulto, A., Lugtenburg, P. J., and de Marie, S. (2008). Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, placebo-controlled trial. Clin. Infect. Dis., 46:1401–1408.
   PubMed Web of Science ®Google Scholar
• Rudokas, M., Najlah, M., Alhnan, M. A., and Elhissi, A. (2016). Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications. Med. Princ. Pract., 25:60–72.
   PubMed Web of Science ®Google Scholar
• Sadrzadeh, N., Miller, D. P., Lechuga-Ballesteros, D., Harper, N. J., Stevenson, C. L., and Bennett, D. B. (2010). Solid-State Stability of Spray-Dried Insulin Powder for Inhalation: Chemical Kinetics and Structural Relaxation Modeling of Exubera above and below the Glass Transition Temperature. J. Pharm. Sci., 99:3698–3710.
   PubMed Web of Science ®Google Scholar
• Shen, X., Hindle, M., and Byron, P. R. (2004). Effect of Energy on Propylene Glycol Aerosols Using the Capillary Aerosol Generator. Int. J. Pharm., 275:249–258.
   PubMed Web of Science ®Google Scholar
• Taut, F. (2006). Use of pulmonary surfactant. US Patent No 6982075.
   Google Scholar
• Tomioka, H., Kuwata, Y., Imanaka, K., Hashimoto, K., Ohnishi, H., Tada, K., Sakamoto, H., and Iwasaki, H. (2005). A Pilot Study of Aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis. Respirology, 10:449–455.
   PubMed Web of Science ®Google Scholar
• Vehring, R. (2008). Pharmaceutical Particle Engineering via Spray Drying. Pharm. Res., 25:999–1022.
   PubMed Web of Science ®Google Scholar
• Walther, F. J., Hernandez-Juviel, J. M., and Waring, A. J. (2014). Aerosol Delivery of Synthetic Lung Surfactant. PeerJ. 2:e403.
   PubMed Web of Science ®Google Scholar
• Waring, A. J., Gupta, M., Gordon, L. M., Fujii, G., and Walther, F. J. (2016). Stability of an Amphipathic Helix-Hairpin Surfactant Peptide in Liposomes. Biochem. Biophys. Acta. Biomembranes, 1858:3113–3119.
   PubMed Web of Science ®Google Scholar
• Weber, A., Morlin, G., Cohen, M., Williams-Warren, J., Ramsey, B., and Smith, A. (1997). Effect of Nebulizer Type and Antibiotic Concentration on Device performance. Pediatr. Pulmonol., 23:249–260.
   PubMed Web of Science ®Google Scholar
• Weers, J., and Tarara, T. (2014). The PulmoSphere™ Platform for Pulmonary Drug Delivery. Ther. Deliv. 5:277–295.
   PubMedGoogle Scholar
• Yeates, D. B. (2012). A Platform for High Dose Rate Delivery of Biotherapeutics. [Abstract]. Presented at Respiratory Drug Delivery conference, Phoenix, Arizona. Respiratory Drug Delivery. 565-568.
   Google Scholar
• Yeates, D. B. (2013a). High Dose Rate Generation of Fine Particle Aerosols of Antibodies with SUPRAER® Compared to Two Mesh Nebulizers. Resp. Drug Deliv., 313–316.
   Google Scholar
• Yeates, D. B. (2013b). Generation of Respirable Antibody Aerosols. J. Aerosol Med. Pulm. Drug Deliv., 26 (2):P090.
   Google Scholar
• Yeates, D. B. (2018). Surfactant Aerosol Therapy for nRDS and ARDS, in Inhalation Aerosols, Physical and Biological Basis for Therapy, A.J. Hickey and H. M. Mansour, eds., 3rd ed., Boca Raton: InformaHealthCare/CRC Press/Taylor & Francis (In Press).
   Google Scholar
• Yeates, D. B., and Heng, X. (2016a). Generation of Respirable Particles from Surfactant Suspensions and Viscous Solutions at High Dose Rates. [Abstract]. Presented at Drug Delivery to the Lungs 27, Edinburgh, UK, December. Drug Deliv. Lungs, 205–208.
   Google Scholar
• Yeates, D. B., and Heng, X. (2016b). Targeting the Optimal Particles Size and Output for Aerosol Drug Delivery Using SUPRAER®. [Abstract]. Presented at Respiratory Drug Delivery conference, Phoenix, Arizona, April. Resp. Drug Deliv., 395–400.
   Google Scholar
• Yeates, D. B., and Heng, X. (2017). Augmentation of the Generation, Processing and Delivery of Surfactant and Macromolecule Aerosols with Heliox. [Abstract]. Presented at 21 ISAM-Congress, Santa Fe, NM, June. J. Aerosol Med. Pulm. Drug. Deliv., 30(3):164.
   Web of Science ®Google Scholar
• Young, P. M., Thompson, J., Woodcock, D., Aydin, M., and Price, R. (2004). The Development of a Novel High-Dose Pressurized Aerosol Dry-Powder Device (PADD) for the Delivery of Pumactant for Inhalation Therapy. J. Aerosol Med., 17:123–128.
   PubMedGoogle Scholar
• Zhu, B., Young, P. M., Ong, H. X., Crapper, J., Flodin, C., Qiao, E. L., Phillips, G., and Traini, D. (2015). Tuning Aerosol Performance Using the Multibreath Orbital® Dry Powder Inhaler Device: Controlling Delivery Parameters and Aerosol Performance via Modification of Puck Orifice Geometry. J. Pharm. Sci., 104:2169–2176.
   PubMed Web of Science ®Google Scholar